-
Pfizer to Meet With U.S. Officials About COVID-19 Booster Shot
drugs
July 13, 2021
Pfizer said it will meet with U.S. officials on Monday to discuss possible authorization for a third booster shot of its COVID-19 vaccine.
-
Pregnant women to receive Moderna COVID-19 vaccine in clinical trial
firstwordpharma
July 13, 2021
According to a posting on ClinicalTrials.gov, Moderna will begin studying its COVID-19 vaccine in pregnant women, Fox Business reported.
-
Why Even the Healthy Need a Primary Care Doctor
drugs
July 12, 2021
A primary care doctor isn't only for when you're sick. Even folks who are generally healthy need a doctor who can help them stay that way.
-
COVID-19 vaccines highly effective in most people in clinical risk groups
firstwordpharma
July 12, 2021
The study from Public Health England (PHE) included more than 1 million people in at-risk groups.
-
OMT skeptical about effectiveness of Janssen Covid-19 vaccine after two weeks
firstwordpharma
July 12, 2021
The Netherlands' Outbreak Management Team (OMT) expressed doubts about whether Johnson & Johnson's single-dose COVID-19 vaccine offers sufficient protection against the Delta variant, reported NL Times.
-
Japan releases study on 'Moderna arm' reaction
firstwordpharma
July 12, 2021
A research team of the Japanese government has released results from its first study on a delayed reaction to Moderna's coronavirus vaccine, reported NHK WORLD-JAPAN.
-
Indonesia health workers to get third vaccine dose
firstwordpharma
July 12, 2021
The Indonesian government has decided to give an additional dose of the Moderna vaccine to healthcare workers, some of whom were infected with the coronavirus and died despite being fully vaccinated with a different vaccine, reported NHK WORLD-JAPAN.
-
Australia’s Delta Outbreak Data Show Vaccines Protect Against Hospitalization
firstwordpharma
July 12, 2021
Early data from Australia's outbreak of the COVID-19 Delta variant suggest that two vaccine doses offer significant protection against severe illness and hospitalization, reported The Wall Street Journal.
-
COVID-19 Treatment Clinical Landscape Research Report 2021: Pandemic Perspectives - US FDA Wastes No Time In COVID-19 Emergency Use Authorization Reviews
prnewswire
July 12, 2021
The commercial outlook for COVID-19 therapeutics is expected to decline progressively throughout 2021 due to the phased implementation of global vaccination programs, which should substantially reduce both outpatient and hospital COVID-19 cases.
-
Argentina announces COVID-19 vaccine supply deal with Moderna
firstwordpharma
July 09, 2021
Argentina says it will sign a COVID-19 vaccine supply agreement with Moderna, as the country attempts to ramp up the inoculation of its population and avoid a possible third wave of coronavirus infections, reported the Financial Post.